Intestinal MRI in Inflammatory Bowel Disease – Literature and Survey-Based Recommendations regarding Reporting by the German Radiological Society (DRG) and the German Competence Network for Inflammatory Bowel Diseases

 

 Permissions and Reprints

Abstract

Background MR-enterography/enteroclysis (MRE) is increasingly used for primary diagnosis, detection of complications, and monitoring of patients with inflammatory bowel disease (IBD). Standardization of reporting is relevant to ensure quality of the methodology and to improve communication between different faculties. The current manuscript describes the features that are required for optimized reporting of MRE in IBD.

Methods An expert consensus panel of radiologists and gastroenterologists conducted a systematic search of the literature. In a Delphi process, members of the German Radiological Society (DRG) and members of the Competence Network for Inflammatory Bowel Diseases voted on relevant criteria for the reporting of findings in MRE. Based on the voting results, statements were developed by the expert consensus panel.

Results Clinically relevant aspects of MRE findings have been defined to optimize reporting and to standardize terminology. Minimal requirements for standardized reporting are suggested. The statements focus on the description of disease activity as well as on complications of IBD. Attributes of intestinal inflammation are described and illustrated by exemplary images.

Conclusion The current manuscript provides standardized parameters and gives practical recommendations on how to report and how to characterize MRE findings in patients with IBD.

Key points: 

1. Systematic overview provides practice-oriented recommendations and names and evaluates the decisive criteria for reporting and interpretation of MRI in inflammatory bowel disease.

2. Standardized terminology and reporting criteria for MRI in IBD improves interdisciplinary communication.

3. Standardized collection and documentation of MRI findings in IBD helps to further establish the method and to improve care for IBD patients.

Citation Format

• Wessling J, Kucharzik T, Bettenworth D et al. Intestinal MRI in Inflammatory Bowel Disease – Literature and Survey-Based Recommendations regarding Reporting by the German Radiological Society (DRG) and the German Competence Network for Inflammatory Bowel Diseases. Fortschr Röntgenstr 2023; 195: 675 – 690

Publication History

Received: 19 August 2022

Accepted: 07 January 2023

Article published online:
03 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Ng SC, Shi HY, Hamidi N. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of populationbased studies. Lancet 2018; 390: 2769-2778 DOI: 10.1016/S0140-6736(17)32448-0.
  CrossrefPubMedGoogle Scholar
• 2 Krankenhausstatistik – Diagnosedaten der Patienten und Patientinnen in Krankenhäusern ab 2000. Statistisches Bundesamt [Destatis] – Zentraler Auskunftsdienst (Eckdaten der vollstationären Patienten und Patientinnen). Gliederungsmerkmale: Jahre, Behandlungs-/Wohnort, ICD10. 2021 Available from: https://www.gbe-bund.de/gbe/pkg_isgbe5.prc_menu_olap?p_uid=gast&p_aid=83782102&p_sprache=D&p_help=0&p_indnr=550&p_indsp=&p_ityp=H&p_fid=
  PubMedGoogle Scholar
• 3 Sturm A, Atreya R, Bettebworth D. et al. Aktualisierte S3-Leitlinie „Diagnostik uund Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2022; 60: 332-418
  PubMedGoogle Scholar
• 4 Dong J. et al. Ultrasound as a diagnostic tool in detecting active Crohnʼs disease: a meta-analysis of prospective studies. Eur Radiol 2014; 24: 26-33
  CrossrefPubMedGoogle Scholar
• 5 Panes J. et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohnʼs disease. Aliment Pharmacol Ther 2011; 34: 125-145
  CrossrefPubMedGoogle Scholar
• 6 Kyunghwan Oh, Eun HyeOh, Soo MinNoh. et al. Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohnʼs Disease Receiving Anti-TNF Therapy. Clinical and Translational Gastroenterology 2022; 13: e00442 DOI: 10.14309/ctg.0000000000000442.
  CrossrefPubMedGoogle Scholar
• 7 Rimola J, Alfaro I, Fernández-Clotet A. et al. Persistent damage on magnetic resonance enterography in patients with Crohnʼs disease in endoscopic remission. Aliment Pharmacol Ther 2018; 48 (11) 1232-1241 DOI: 10.1111/apt.15013.
  CrossrefPubMedGoogle Scholar
• 8 Ordas I, Rimola J, Rodriguez S. et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohnʼs disease. Gastroenterology 2014; 146: 374-382.e371.21
  CrossrefPubMedGoogle Scholar
• 9 Sauer CG, Middleton JP, McCracken C. et al. Magnetic resonance enterography healing and magnetic resonance enterography remission predicts improved outcome in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2016; 62: 378-383
  CrossrefPubMedGoogle Scholar
• 10 Deepak P, Fletcher JG, Fidler JL. et al. Radiological response is associated with better long-term outcomes and is a poten -tial treatment target in patients with small bowel Crohnʼs disease. Am J Gastroenterol 2016; 111: 997-1006
  CrossrefPubMedGoogle Scholar
• 11 Grand DJ, Guglielmo FF, Al-Hawary MM. MR enterography in Crohnʼs disease: current consensus on optimal imaging technique and future advances from the SAR Crohnʼs disease-focused panel. Abdom Imaging 2015; 40: 953-964
  CrossrefPubMedGoogle Scholar
• 12 Bruining DH, Zimmermann EM, Loftus Jr EV. et al. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohnʼs Disease. Gastroenterology 2018; 154: 1172-1194
  CrossrefPubMedGoogle Scholar
• 13 Thipphavong S, Costa AF, Ali HA. et al. Structured reporting of MRI for perianal fistula. Abdominal Radiology 2018; 44: 1295-1305
  CrossrefPubMedGoogle Scholar
• 14 Halligan S, Tolan D, Amitai MM. et al. ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis. European radiology 2020; 30: 4734-4740
  CrossrefPubMedGoogle Scholar
• 15 Kucharzik T, Tielbeek J, Carter D. et al. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in IBD. J Crohns Colitis 2022; 16 (04) 523-543 DOI: 10.1093/ecco-jcc/jjab180.
  CrossrefPubMedGoogle Scholar
• 16 Kucharzik T, Atreyab R, Bachmann O. et al. Positionspapier zur Befunderhebung von Darmultraschallbefunden bei chronisch entzündlichen Darmerkrankungen. Z Gastroenterol 2022; 60: 978-990
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Rimola J, Rodriguez S, Garcia-Bosch O. et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohnʼs disease. Gut 2009; 58: 1113-1120
  CrossrefPubMedGoogle Scholar
• 18 Steward MJ, Punwani S, Proctor I. et al. Non-perforating small bowel Crohnʼs disease assessed by MRI enterography: derivation and histopathological validation of an MRbased activity index. Eur J Radiol 2012; 81: 2080-2088
  CrossrefPubMedGoogle Scholar
• 19 Hordonneau C, Buisson A, Scanzi J. et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohnʼs disease: validation of quantitative index of activity. Am J Gastroenterol 2014; 109: 89-98
  CrossrefPubMedGoogle Scholar
• 20 Makanyanga JC, Pendse D, Dikaios N. et al. Evaluation of Crohnʼs disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol 2014; 24: 277-287
  CrossrefPubMedGoogle Scholar
• 21 Ordás I, Rimola J, Alfaro I. et al. Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohnʼs Disease. Gastroenterology 2019; 157: 432-439.e1
  CrossrefPubMedGoogle Scholar
• 22 Deepak P, Fletcher JG, Fidler JL. et al. Computed tomography and magnetic resonance enterography in Crohnʼs disease: assessment of radiologic criteria and endpoints for clinical practice and trials. Inflamm Bowel Dis 2016; 22: 2280-2288
  CrossrefPubMedGoogle Scholar
• 23 Goodsall TM, Jairath V, Feagan BG. et al. Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohnʼs disease. Aliment Pharmacol Ther 2021; 53: 873-886
  CrossrefPubMedGoogle Scholar
• 24 Messadeg L, Hordonneau C, Bouguen G. et al. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohnʼs Disease Treated with Anti-Tumour Necrosis Factor Therapy. Journal of Crohnʼs and Colitis 2020; 14: 1524-1534
  CrossrefPubMedGoogle Scholar
• 25 Bodily KD, Fletcher JG, Solem CA. et al. Crohn Disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 2006; 238: 505-516
  CrossrefPubMedGoogle Scholar
• 26 Church PC, Turner D, Feldman BM. et al. Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohnʼs disease. Aliment Pharmacol Ther 2015; 41: 153-166
  CrossrefPubMedGoogle Scholar
• 27 Horsthuis K, Bipat S, Bennink RJ. et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008; 247: 64-79
  CrossrefPubMedGoogle Scholar
• 28 Qiu Y, Mao R, Chen BL. et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohnʼs disease. Aliment Pharmacol Ther 2014; 40: 134-146
  CrossrefPubMedGoogle Scholar
• 29 Siddiki H, Fletcher JG, Hara AK. et al. Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohnʼs disease in the small bowel. Inflamm Bowel Dis 2011; 17: 778-786
  CrossrefPubMedGoogle Scholar
• 30 Nylund K, Hausken T, Ødegaard S. et al. Gastrointestinal Wall Thickness Measured with Transabdominal Ultrasonography and Its Relationship to Demographic Factors in Healthy Subjects. Ultraschall in der Medizin – European Journal of Ultrasound 2012; 33: E225-E232
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Goodsall TM, Nguyen TM, Parker CE. et al. Systematic Review: Gastrointestinal Ultrasound Scoring Indizes for Inflammatory Bowel Disease. J Crohns Colitis 2021; 15: 125-142
  CrossrefPubMedGoogle Scholar
• 32 Taylor SA, Mallett S, Bhatnagar G. et al. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohnʼs disease (METRIC): a multicentre trial. The Lancet Gastroenterology & Hepatology 2018; 3: 548-558
  CrossrefPubMedGoogle Scholar
• 33 Hallé E, Azahaf M, Duveau N. et al. Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohnʼs Disease. Digestive Diseases and Sciences 2019; 65: 2664-2674
  CrossrefPubMedGoogle Scholar
• 34 Kucharzik T, Wittig BM, Helwig U. et al. Use of Intestinal Ultrasound to Monitor Crohnʼs Disease Activity. Clinical Gastroenterology and Hepatology 2017; 15: 535-542
  CrossrefPubMedGoogle Scholar
• 35 Maaser C, Petersen F, Helwig U. et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut 2020; 69: 1629-1636
  CrossrefPubMedGoogle Scholar
• 36 Maconi G, Nylund K, Ripolles T. et al. EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases. Ultraschall in der Medizin – European Journal of Ultrasound 2018; 39: 304-317
  Article in Thieme ConnectPubMedGoogle Scholar
• 37 Wilkens R, Hagemann-Madsen RH, Peters DA. et al. Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn′s Disease. Journal of Crohnʼs and Colitis 2017; 12: 48-56
  CrossrefPubMedGoogle Scholar
• 38 Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. Am J Roentgenol 2001; 176: 1105-1116
  CrossrefPubMedGoogle Scholar
• 39 Plumb AA, Pendse DA, McCartney S. et al. Lymphoid nodular hyperplasia of the terminal ileum can mimic active crohn disease on MR enterography. Am J Roentgenol 2014; 203: W400-W40
  CrossrefPubMedGoogle Scholar
• 40 Baker ME, Walter J, Obuchowski NA. et al. Mural attenuation in normal small bowel and active inflammatory Crohnʼs disease on CT enterography: location, absolute attenuation, relative attenuation, and the effect of wall thickness. Am J Roentgenol 2009; 192: 417-423
  CrossrefPubMedGoogle Scholar
• 41 Louis E, Collard A, Oger AF. et al. Behaviour of Crohnʼs disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782
  CrossrefPubMedGoogle Scholar
• 42 Rieder F, Bettenworth D, Ma C. et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohnʼs disease. Aliment Pharmacol Ther 2018; 48: 347-357
  CrossrefPubMedGoogle Scholar
• 43 Guglielmo FF, Anupindi SA, Fletcher JG. et al. Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms. Radiographics 2020; 40: 354-375
  CrossrefPubMedGoogle Scholar
• 44 Bossuyt P, Debeuckelaere C, Ferrante M. et al. Risk Stratification for Surgery in Stricturing Ileal Crohnʼs Disease: The BACARDI Risk Model. J Crohns Colitis 2018; 12: 32-38
  CrossrefPubMedGoogle Scholar
• 45 Bouhnik Y, Carbonnel F, Laharie D. et al. Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 2018; 67: 53-60
  PubMedGoogle Scholar
• 46 Chaudhry NA, Riverso M, Grajo JR. et al. A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohnʼs Disease. Inflamm Bowel Dis 2017; 23: 641-649
  CrossrefPubMedGoogle Scholar
• 47 Schulberg JD, Wright EK, Holt BA. et al. Magnetic resonance enterography for predicting the clinical course of Crohnʼs disease strictures. J Gastroenterol Hepatol 2020; 35: 980-987
  PubMedGoogle Scholar
• 48 Stocker D, King MJ, El Homsi M. et al. Luminal narrowing alone allows an accurate diagnosis of Crohnʼs disease small bowel strictures at cross-sectional imaging. J Crohns Colitis 2021; 22 (06) 1009-1018 DOI: 10.1093/ecco-jcc/jjaa256.
  CrossrefPubMedGoogle Scholar
• 49 Panes J. et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohnʼs disease. Aliment Pharmacol Ther 2011; 34: 125-145
  CrossrefPubMedGoogle Scholar
• 50 Bettenworth D, Gustavsson A, Atreja A. et al. A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohnʼs Disease. Inflamm Bowel Dis 2017; 23 (01) 133-142 DOI: 10.1097/MIB.0000000000000988.
  CrossrefPubMedGoogle Scholar
• 51 Rieder F, Zimmermann EM, Remzi FH. et al. Crohnʼs disease complicated by strictures: a systematic review. Gut 2013; 62: 1072-1084
  CrossrefPubMedGoogle Scholar
• 52 Li C, Kuemmerle JF. Mechanisms that mediate the development of fibrosis in patients with Crohnʼs disease. Inflamm Bowel Dis 2014; 20: 1250-1258
  CrossrefPubMedGoogle Scholar
• 53 Zidar N, Langner C, Jerala M. et al. Pathology of fibrosis in Crohnʼs disease – contribution to understanding ist pathogenesis. Front Med (Lausanne) 2020; 7: 167 DOI: 10.3389/fmed.2020.00167.eCollection 2020.
  CrossrefPubMedGoogle Scholar
• 54 Rimola J, Capozzi N. Differentiation of fibrotic and inflammatory component of Crohnʼs disease-associated strictures. Intest Res 2020; 18: 144-150
  CrossrefPubMedGoogle Scholar
• 55 Baumgart DC, Muller HP, Grittner U. et al. US-based Real-time Elastography for the Detection of Fibrotic Gut Tissue in Patients with Stricturing Crohn Disease. Radiology 2015; 275: 889-899
  CrossrefPubMedGoogle Scholar
• 56 Allocca M, Fiorino G, Bonifacio C. et al. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohnʼs Disease. Clin Gastroenterol Hepatol 2019; 17: 2397-2415
  PubMedGoogle Scholar
• 57 Allocca M, Fiorino G, Bonifacio C. et al. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohnʼs Disease. Clin Gastroenterol Hepatol 2019; 17: 2397-2415
  CrossrefPubMedGoogle Scholar
• 58 Orscheln ES, Dillman JR, Towbin AJ. et al. Penetrating Crohn disease: does it occur in the absence of stricturing disease?. Abdom Radiol (NY) 2018; 43: 1583-1589
  CrossrefPubMedGoogle Scholar
• 59 Bouhnik Y, Carbonnel F, Laharie D. et al. Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 2018; 67: 53-60
  CrossrefPubMedGoogle Scholar
• 60 Schulberg JD, Wright EK, Holt BA. et al. Magnetic resonance enterography for predicting the clinical course of Crohnʼs disease strictures. J Gastroenterol Hepatol 2020; 35: 980-987
  CrossrefPubMedGoogle Scholar
• 61 Weber NK, Fletcher JG, Fidler JL. et al. Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohnʼs disease. Abdom Imaging 2015; 40: 1060-1067
  CrossrefPubMedGoogle Scholar
• 62 Radmard AR, Amouei M, Kooraki S. et al. Potenzial MR Enterography Features to Differentiate Primary Small Intestinal Lymphoma from Crohn Disease. American Journal of Roentgenology 2020; 215: 864-873
  CrossrefPubMedGoogle Scholar
• 63 Palascak-Juif V, Bouvier AM, Cosnes J. et al. Small bowel adenocarcinoma in patients with Crohnʼs disease compared with small bowel adenocarcinom de novo. Inflamm Bowel Dis 2005; 11: 828-832
  CrossrefPubMedGoogle Scholar
• 64 Schreyer AG, Menzel C, Friedrich C. et al. Comparison of high-resolution ultrasound and MR-enterography in patients with inflammatory bowel disease. World J Gastroenterol 2011; 17 (08) 1018-1025 DOI: 10.3748/wjg.v17.i8.1018.
  CrossrefPubMedGoogle Scholar
• 65 Rimola J, Ordas I, Rodriguez S. et al. Magnetic resonance imaging for evaluation of Crohnʼs disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17: 1759-1768
  CrossrefPubMedGoogle Scholar
• 66 Tielbeek JA, Makanyanga JC, Bipat S. et al. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity. Am J Roentgenol 2013; 201: 1220-1228
  CrossrefPubMedGoogle Scholar
• 67 Park SH. DWI at MR enterography for evaluating bowel inflammation in Crohn disease. Am J Roentgenol 2016; 1-9
  PubMedGoogle Scholar
• 68 Hordonneau C, Buisson A, Scanzi J. et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohnʼs disease: validation of quantitative index of activity. Am J Gastroenterol 2014; 109: 89-98
  CrossrefPubMedGoogle Scholar
• 69 Buisson A, Joubert A, Montoriol PF. et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohnʼs disease. [Erratum appears in Aliment Pharmacol Ther 2013; 37: 1031 Note: Ines, D D [corrected to Da Ines, D]]. Aliment Pharmacol Ther 2013; 37: 537-545
  PubMedGoogle Scholar
• 70 Seo N, Park SH, Kim KJ. et al. MR enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion-weighted imaging without intravenous contrast material: a prospective noninferiority study. Radiology 2016; 278: 762-772
  CrossrefPubMedGoogle Scholar
• 71 Kim K-J, Lee Y, Park SH. et al. Diffusion-weighted MR Enterography for Evaluating Crohnʼs Disease. Inflammatory Bowel Diseases 2015; 21: 101-109
  CrossrefPubMedGoogle Scholar
• 72 Punwani S, Rodriguez-Justo M, Bainbridge A. et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009; 252: 712-720
  CrossrefPubMedGoogle Scholar
• 73 Maccioni F, Staltari I, Pino AR. et al. Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohnʼs disease. Abdom Imaging 2012; 37: 944-957
  CrossrefPubMedGoogle Scholar
• 74 Choi SH, Kim KW, Lee JY. et al. Diffusionweighted magnetic resonance enterography for evaluating bowel inflammation in Crohnʼs disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2016; 22: 669-679
  CrossrefPubMedGoogle Scholar
• 75 Morani AC, Smith EA, Ganeshan D. et al. Diffusion-weighted MRI in pediatric inflammatory bowel disease. Am J Roentgenol 2015; 204: 1269-127746
  CrossrefPubMedGoogle Scholar
• 76 Bots S, Nylund K, Löwenberg M. et al. Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores. Journal of Crohnʼs and Colitis 2018; 12: 920-929
  CrossrefPubMedGoogle Scholar
• 77 Ripollés T, Martínez MJ, Paredes JM. et al. Crohn Disease: Correlation of Findings at Contrast-enhanced US with Severity at Endoscopy. Radiology 2009; 253: 241-248
  CrossrefPubMedGoogle Scholar
• 78 Esteban J, Maldonado L, Sanchiz V. et al. Activity of Crohnʼs disease assessed by colour Doppler ultrasound analysis of the affected loops. European Radiology 2001; 11: 1423-1428
  CrossrefPubMedGoogle Scholar
• 79 Ripollés T, Paredes JM, Martínez-Pérez MJ. et al. Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-year Sonographic Response and Clinical Outcome in Crohnʼs Disease. Inflammatory Bowel Diseases 2016; 22: 2465-2473
  CrossrefPubMedGoogle Scholar
• 80 Novak KL, Nylund K, Maaser C. et al. Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohnʼs Disease. J Crohns Colitis 2021; 15: 609-616
  CrossrefPubMedGoogle Scholar
• 81 Makanyanga J, Punwani S, Taylor SA. Assessment of wall inflammation and fibrosis in Crohnʼs disease: value of T1-weighted gadolinium-enhanced MR imaging. Abdom Imaging 2012; 37: 933-943
  CrossrefPubMedGoogle Scholar
• 82 Church PC, Turner D, Feldman BM. et al. Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohnʼs disease. Aliment Pharmacol Ther 2015; 41: 153-166
  CrossrefPubMedGoogle Scholar
• 83 Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: „vascular jejunization of the ileum“ or the „comb sign“. Abdom Imaging 1995; 20: 327-332
  CrossrefPubMedGoogle Scholar
• 84 Bots S, Nylund K, Löwenberg M. et al. Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores. Journal of Crohnʼs and Colitis 2018; 12: 920-929
  CrossrefPubMedGoogle Scholar
• 85 Menys A, Puylaert C, Tutein Nolthenius CE. et al. Quantified Terminal Ileal Motility during MR Enterography as a Biomarker of Crohn Disease Activity: Prospective MultiInstitution Study. Radiology 2018; 289: 428-435
  CrossrefPubMedGoogle Scholar
• 86 Girometti R, Zuiani C, Toso F. et al. MRI Scoring System Including Dynamic Motility Evaluation in Assessing the Activity of Crohnʼs Disease of the Terminal Ileum. Academic Radiology 2008; 15: 153-164
  CrossrefPubMedGoogle Scholar
• 87 Magro F, Langner C, Driessen A. et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013; 7: 827-851
  CrossrefPubMedGoogle Scholar
• 88 Rees MA, Dillman JR, Anton CG. et al. Inter-radiologist agreement using Society of Abdominal Radiology-American Gastroenterological Association (SAR-AGA) consensus nomenclature for reporting CT and MR enterography in children and young adults with small bowel Crohn disease. Abdom Radiol (NY) 2019; 44: 391-397
  CrossrefPubMedGoogle Scholar
• 89 Herrmann KA, Michaely HJ, Zech CJ. et al. Internal fistulas in Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 2006; 31: 675-687
  CrossrefPubMedGoogle Scholar
• 90 Braithwaite KA, Alazraki AL. Use of the star sign to diagnose internal fistulas in pediatric patients with penetrating Crohn disease by MR enterography. Pediatr Radiol 2014; 44: 926-931
  CrossrefPubMedGoogle Scholar
• 91 Sampietro GM, Casiraghi S, Foschi D. Perforating Crohnʼs disease: conservative and surgical treatment. Dig Dis 2013; 31: 218-221
  CrossrefPubMedGoogle Scholar
• 92 Oberhuber G, Stangl PC, Vogelsang H. et al. Significant association of strictures and internal fistula formation in Crohnʼs disease. Virchows Arch 2000; 437: 293-297
  CrossrefPubMedGoogle Scholar
• 93 Baker ME, Fletcher JG, Al-Hawary M. et al. Interdisciplinary Updates in Crohnʼs Disease Reporting Nomenclature, and Cross-Sectional Disease Monitoring. Radiol Clin North Am 2018; 56: 691-707
  CrossrefPubMedGoogle Scholar
• 94 Tozer PJ, Whelan K, Phillips RK. et al. Etiology of perianal Crohnʼs disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis 2009; 15: 1591-1598
  CrossrefPubMedGoogle Scholar
• 95 Gecse KB, Bemelman W, Kamm MA. et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohnʼs disease. Gut 2014; 63: 1381-1392
  CrossrefPubMedGoogle Scholar
• 96 Feuerstein JD, Ho EY, Shmidt E. et al. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohnʼs Disease. Gastroenterology 2021; 160 (07) 2496-2508 DOI: 10.1053/j.gastro.2021.04.022.
  CrossrefPubMedGoogle Scholar
• 97 Patil SA, Cross RK. Medical versus surgical management of penetrating Crohnʼs disease: the current situation and future perspectives. Expert Rev Gastroenterol Hepatol 2017; 11: 843-848
  CrossrefPubMedGoogle Scholar
• 98 Dietrich CF, Lorentzen T, Appelbaum L. et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III – Abdominal Treatment Procedures (Short Version). Ultraschall in Med 2016; 37: 27-45
  Article in Thieme ConnectPubMedGoogle Scholar
• 99 Ripollés T, Martínez-Pérez MJ, Paredes JM. et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohnʼs disease and other abdominal conditions. Eur J Radiol 2013; 82: e525-e531
  CrossrefPubMedGoogle Scholar
• 100 Violi NV, Schoepfer AM, Fournier N. et al. Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort. Am J Roentgenol 2014; 203: 62-69
  CrossrefPubMedGoogle Scholar
• 101 Levine A, Griffiths A, Markowitz J. et al. Pediatric modification oft he Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011; 17: 1314-1321
  CrossrefPubMedGoogle Scholar
• 102 Pariente B, Cosnes J, Danese S. et al. Development oft he Crohnʼs disease digestive damage score, the Lemann score. Inflamm Bowel Dis 2011; 17: 1415-1422
  CrossrefPubMedGoogle Scholar
• 103 Cosnes J, Cattan S, Blain A. et al. Long term evolution of disease behaviour of Crohnʼs disease. Inflamm Bowel Dis 2002; 8: 244-250
  CrossrefPubMedGoogle Scholar